Serhii Kernychnyi

Serhii Kernychnyi

Auto-generated profile, based on publicly available information

Serhii Kernychnyi

Higher Education Institution “Podilskyi State University”, Kamianets-Podilskyi, Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2023 in World's Veterinary Journal
Verified
Journal Article
Closed access
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKSerhii Kernychnyi
Serhii Kernychnyi
TBTamara Betlinska
Tamara Betlinska
Discoid lupus erythematosus is lupus in dogs an autoimmune disease that affects the skin. A 6-year-old, 38 kg, male German Shepherd dog was taken to the Small Animal Hospital at the University in Kyiv, Ukraine with a history of progressive skin lesions. The indications of discoid lupus erythematosus in dogs manifested as red, scaly macules or papules on the skin's surface. These gradually develop into follicular plugging, disc-shaped plaques with adherent scales, and peripheral hyperpigmentation. The oral hydroxychloroquine was used for medication and the prescribed dosage was 5.0 mg per kilogram of the dog's weight, administered once daily. The hydroxychloroquine was gradually reduced and discontinued within a month. Concomitant with the hydroxychloroquine treatment, the application of tacrolimus cream (Protopic® 0.03%) was initiated. The veterinary physician also advised the dog owner to limit sun exposure to avoid any adverse effects. After a four-week period, there was a decrease in pruritus and erythema, and plaques had flattened although the skin still had some patchy hyperpigmentation. Approximately 3-4 weeks later, the veterinarian determined that the dog had achieved clinical remission as all the skin lesions had become completely flattened. The use of deproteinized calf blood extract gel (Solcoseril® Gel for external 4.15 mg/1 g, Legacy led to the complete disappearance of the initial redness and prevented the appearance of new skin lesions. These results can be considered as a safe and effective alternative to conventional treatment methods.

17 May 2020 in Ukrainian Journal of Veterinary and Agricultural Sciences
Verified
Journal Article
Open access
PDF file
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKS. P. Kernychnyi
S. P. Kernychnyi
VMV. P. Mizyk
V. P. Mizyk
ODO. Y. Dmytriv
O. Y. Dmytriv
TBT. V. Betlinska
T. V. Betlinska
The reproductive function of cows is ensured by a homeostasis system. The aim of this study to investigate scientific data and analyze modern practical approaches related to metabolic disorders. Also investigating immune response. The object of the research was the cows (Bos taurus taurus) of Ukrainian Black-and-White dairy breed. Using the method in groups and periods. The control group of animals The control group of animals (C1, n=137) – cows with a physiological of pregnancy (248-255 days). Re-examination of control animals (C2, n=137) was carried out during the postpartum period. The first experimental group (E1, n = 32) consisted of animals diagnosed with preeclampsia. Cows with a subclinical course of ketosis constituted the second group (E2, n = 52). The development of preeclampsia of cows was accompanied by an increase in the content of medium-sized peptides from 0.2 ± 0.01 to 0.3 ± 0.03 Mol.Wt. (P < 0.01), and an increase in the level of average molecular circulating immune complexes. It is proved that an imbalance in the diet and a deficiency of metabolic energy during the dry period and for 6-8 weeks after birth negatively affects the health of animals, is the cause of metabolic disorders and the manifestation of reproductive pathologies.

25 December 2023 in World's Veterinary Journal
Verified
Journal Article
Closed access
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKSerhii Kernychnyi
Serhii Kernychnyi
TBTamara Betlinska
Tamara Betlinska

23 April 2025 in Ukrainian Journal of Veterinary and Agricultural Sciences
Verified
Journal Article
Open access
PDF file
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKS. P. Kernychnyi
S. P. Kernychnyi
ODO. Ya. Dmytriv
O. Ya. Dmytriv
TBT. V. Betlinska
T. V. Betlinska
Melatonin is a multifunctional hormone with diverse physiological roles, particularly in immune regulation and reproductive health. While primarily synthesized by the pineal gland in response to the circadian rhythm, melatonin is also produced in extrapineal tissues such as the placenta, gastrointestinal tract, and reproductive organs, highlighting its systemic significance. Beyond its role in sleep-wake cycle regulation, melatonin exhibits potent antioxidant, anti-inflammatory, and immunomodulatory properties, making it essential for maintaining cellular homeostasis and overall physiological stability. In the immune system, melatonin contributes to both innate and adaptive immunity by modulating cytokine production, reducing oxidative stress, and enhancing immune cell activity. It plays a protective role against infections and inflammatory diseases by suppressing pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) while promoting anti-inflammatory cytokines like interleukin-10 (IL-10). Additionally, melatonin influences immune tolerance, which is critical for preventing autoimmune responses and ensuring successful pregnancy. In females, melatonin improves oocyte quality, embryo development, and pregnancy outcomes by protecting ovarian follicles from oxidative damage, regulating steroidogenesis, and supporting placental function. Its role in fetal development is particularly significant, as it contributes to maternal-fetal circadian signaling, placental vascularization, and epigenetic modifications that influence gene expression. In men, melatonin contributes to spermatogenesis and improves sperm quality by boosting mitochondrial activity, decreasing oxidative stress, and safeguarding sperm DNA from damage. Additionally, it helps regulate hormone production in the testes, maintaining optimal reproductive health. Given its pleiotropic effects, melatonin holds substantial therapeutic potential for addressing immune dysfunction, reproductive disorders, and pregnancy complications. Future research should focus on clinical applications of melatonin supplementation in treating infertility, pregnancy-related complications, and immune-mediated diseases. Understanding the intricate relationship between melatonin, immunity, and reproduction may pave the way for innovative therapeutic strategies in both human and veterinary medicine. Melatonin is a multifunctional hormone with essential roles in immune regulation and reproductive health. Beyond its well-known function in circadian rhythm regulation, melatonin exerts potent antioxidant, anti-inflammatory, and immunomodulatory effects. It plays a critical role in maintaining immune homeostasis by reducing oxidative stress, modulating cytokine production, and enhancing immune cell function, thereby offering protection against infections and inflammatory disorders. In reproduction, melatonin influences key processes such as oocyte maturation, embryo development, and pregnancy maintenance. It supports fertility by improving ovarian function, regulating gonadotropin secretion, and protecting reproductive tissues from oxidative damage. Additionally, melatonin's involvement in placental function and fetal development highlights its significance in ensuring successful gestation. Given its widespread physiological effects, melatonin presents promising therapeutic potential for addressing immune-related and reproductive disorders. Future research exploring its clinical applications may lead to novel strategies for enhancing reproductive success and immune resilience in both human and veterinary medicine.

30 March 2025 in World's Veterinary Journal
Verified
Journal Article
Closed access
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKSerhii Kernychnyi
Serhii Kernychnyi
TZTatiana Zakharova
Tatiana Zakharova
TBTamara Betlinska
Tamara Betlinska
MLMaksym Luchkа
Maksym Luchkа
Canine mast cell tumors, a tumor originating from mast cells involved in allergic reactions and inflammation, are among the most common skin tumors in dogs. The present study aimed to explore the clinical features, diagnostic approaches, and prognosis of canine mastocytomas through a case study. A 5-year-old male Akita, weighing 35.8 kg, was brought to the Doctor VET veterinary clinic in Kamianets-Podilskyi, Ukraine, for evaluation. Upon initial examination, the dog had a body temperature of 38.5°C, a heart rate of 74 beats per minute (bpm), and a respiratory rate of 28 breaths per minute, all of which were within normal physiological limits. The animal was alert and responsive and displayed no signs of systemic distress. A detailed physical examination revealed a tumor located 35.2 mm below the plantar surface of the tarsal joint (art. tarsi). The tumor was round, mobile, and surrounded by a thin fibrous capsule, with no signs of pain or discomfort during palpation. Cytological analysis showed a high-cellularity smear with numerous mast cells scattered throughout the field. These cells were round to oval in shape with abundant cytoplasm containing dense, basophilic to metachromatic granules. The hematological evaluation indicated a systemic inflammatory or immune response triggered by the tumor, as evidenced by neutrophilic leukocytosis (73.1%; 8.89×10⁹/L). Biochemical analysis revealed an elevated alkaline phosphatase activity level (4.45 μmol/L), suggesting systemic involvement. The tumor was surgically excised, ensuring complete removal with wide margins to minimize the risk of recurrence. Histological examination of the excised tissues confirmed a densely cellular neoplastic infiltrate composed predominantly of mast cells arranged in sheets and clusters. The mast cells displayed significant cellular and nuclear pleomorphism, characterized by moderate to marked anisocytosis and anisokaryosis. While no significant necrosis was observed, scattered apoptotic bodies were present, indicating ongoing cellular turnover. This case highlighted the critical importance of early diagnosis and comprehensive management of canine mastocytomas. Low-grade tumors often carry a favorable prognosis when treated promptly and appropriately. However, higher-grade or poorly differentiated tumors may require multimodal therapeutic approaches to achieve better outcomes.

26 February 2026 in Ukrainian Journal of Veterinary and Agricultural Sciences
Verified
Journal Article
Open access
MZMykola Zhelavskyi
Mykola Zhelavskyi
SKS. P. Kernychnyi
S. P. Kernychnyi
ODO. Ya. Dmytriv
O. Ya. Dmytriv
TBT. V. Betlinska
T. V. Betlinska
Wound healing in cats remains a clinically relevant challenge due to species-specific anatomical features, prolonged inflammatory responses, and a relatively high risk of delayed epithelialization. The present case report evaluated the clinical efficacy and systemic safety of topical application of ASD fraction 3 ointment as an adjuvant therapy for the treatment of a cervical skin wound in a cat, with particular emphasis on wound healing dynamics, inflammatory status, metabolic balance, and potential adverse effects. At the initiation of treatment (Day 1), the cat presented with an open, round wound located in the cervical region, measuring 4.75 cm in diameter. The wound surface exhibited moderate edema, hyperemia of the surrounding tissues, and serosanguineous exudation, consistent with the inflammatory phase of wound healing. Topical ASD fraction 3 ointment was applied according to the treatment protocol, and the animal was monitored through regular clinical examinations as well as serial hematological and biochemical assessments conducted on Days 1, 7, 14, and 21. By Day 7 of treatment, a marked reduction in wound size was observed, with the wound area decreasing to approximately 65–70 % of the initial value. This reduction was accompanied by a noticeable decrease in exudation, contraction of the wound margins, and formation of viable granulation tissue. By day 14, further wound contraction was recorded, with the residual wound area reduced to approximately 20–25 % of baseline, indicating active epithelialization and progression toward tissue repair. Complete clinical wound healing was achieved by Day 21, characterized by full restoration of skin integrity and the formation of a thin, elastic scar without signs of inflammation or local complications. Hematological evaluation at baseline revealed moderate leukocytosis with neutrophilia, reflecting an active localized inflammatory response. During the course of treatment, leukocyte counts and differential parameters progressively normalized, indicating effective resolution of inflammation. Biochemical analysis demonstrated transient hypoproteinemia and hypoalbuminemia at the initial stage, followed by gradual normalization during healing. Liver and renal function markers remained within physiological reference ranges throughout the observation period, suggesting the absence of systemic toxicity associated with the topical use of ASD fraction 3 ointment. In conclusion, topical application of ASD fraction 3 ointment was associated with favorable wound healing dynamics, controlled inflammatory response, maintenance of metabolic balance, and no detectable adverse systemic effects. These findings suggest that ASD-based topical therapy may represent a promising adjunctive option for wound management in cats, warranting further controlled and comparative studies.